Up for Grabs<br />By Rev Shark<br />RealMoney.com Contributor<br />12/18/2009 8:33 AM EST<br /><br /> In every battle there comes a time when both sides consider themselves beaten, then he who continues the attack wins.<br /> -- Ulysses S. Grant<br /><br />On Thursday the bears finally managed to put some points on the scoreboard, but it was relatively mild and orderly selling. There were a number of negatives, including poor demand for the Citigroup (C) secondary offering, worse-than-expected weekly unemployment claims, poor earnings and guidance from FedEx (FDX) and a stronger dollar.<br /><br />That is a pretty good lineup of negatives, but all the bears managed to do was push the indices back down into the middle of the recent trading range. There was no real panic-selling or any strong momentum to the downside.<br /><br />The bears are in pretty good shape to press their slight advantage after the poor action on Thursday, but we saw strong earnings reports after the close from Research In Motion (RIMM) , Nike (NKE) and Oracle (ORCL) , and financials are trying to stabilize after digesting $53 billion in secondary offerings. If these positives persist, then the advantage is going to shift back to the bulls and leave the market in the middle of its recent trading range.<br /><br />The problem this market has had lately is that there haven't been any strong trends or emotions. I was hopeful yesterday that the bears might press a bit and shake things up, but they just didn't seem to have much conviction, either.<br /><br />We have had little leadership lately and few strong themes. We did see gold fall sharply as the dollar rallied, and banks have clearly been out of favor, but as far as the upside goes, the strength has been very random with a few big-cap names perking up here and there but no really dominant pockets of momentum.<br /><br />It is going to be interesting to see if the strength in RIMM and ORCL might spark some love for the big-caps into the end of the year. If we are going to run a bit over the next two weeks, the most logical leaders are going to be Google (GOOG) , Apple (AAPL) , Amazon (AMZN) , RIMM, Priceline (PCLN) and other higher-beta big-cap names.<br /><br />Both bulls and bears have had a chance to take control of this market recently, but it is still up for grabs. It is the bulls' turn again this morning, and I'm just rooting for some conviction so we can get a little trend working. It has been a very dull market lately, and if we don't have some better action soon, market players are going to lock in gains and sit on the sidelines while they enjoy the holidays.<br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: SMOD +12.4%, RIMM +11.0% (also upgraded to Hold at Deutsche, initiated with Hold at Standpoint), DEER +9.4%, KMX +8.6%, TTWO +6.8% (also upgraded to Hold at Kaufman, upgraded to Buy from Neutral at Sterne Agee), ORCL +4.2%, NKE +2.1%, APSG +1.0%... M&A news: JAV +13.8% (to be acquired by Myriad Pharmaceuticals)... Select financials trading higher: MFG +2.0%, STT +1.9% (upgraded to Outperform at Keefe Bruyette), GNW +1.7% (Northland Securities believes investors have a very cheap entry point with a visible path to $15.75, and with continued ROE growth, the stock could be worth $25-$30/share), STD +1.4%, BAC +1.1%, CS +1.0%... Select oil/gas related names showing strength: HES +2.8% (initiated with Buy at BofA/Merrill), BP +2.2% (raised to Buy from Neutral at Goldman- DJ), RIG +1.9%, CHK +1.8% (Cramer makes positive comments on MadMoney), RDS.A +1.7%, WFT +1.5%, APA +1.5% (initiated with Buy at BofA/Merrill), APC +1.2% (initiated with Buy at BofA/Merrill), STO +1.2%... Select metals/mining names showing early strength: GOLD +4.9%, RTP +2.2%, BHP +1.9%, BBL +1.8%, AUY +1.4%, GFI +1.3%... Other news: SENO +21.3% (announces that a jury delivered a verdict in favor of SenoRx in a lawsuit brought by Hologic), CRME +13.8% (announces investigational candidate, vernakalant, meets primary endpoint in European Comparator study), CELG +5.8% (Initial data from CALGB-Led study of treatment with continuous REVLIMID in patients with multiple myeloma following autologous stem cell transplant reported),RYAAY +4.0% (Ryanair ends talks with Boeing on 737 order - WSJ), SNY +2.9% (still checking), NOK +1.0% (up in sympathy with RIMM)... Analyst comments: ALTI +7.4% (initiated with Overweight at Weisel), DAN +2.7% (upgraded to Overweight at JPMorgan), EMC +2.5% (added to Conviction Buy list at Goldman- Reuters), ETFC +2.5% (resumed with a Buy at BofA/Merrill), STRI +2.4% (initiated with Outperform at Macquarie).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: AIQ -10.1%, PALM -6.1%, BCR -4.9% (also downgraded to Underweight at Piper, downgraded to Mkt Perform from Outperform at William Blair), ACN -1.3%, DRI -1.1%... M&A news: MYRX -3.2% (JAV to be acquired by Myriad Pharmaceuticals)... Other news: LDK -9.8% (hearing early weakness attributed to prcing of offering), KOG -8.4% (announces preliminary 2010 capex budget of $60 mln), ZLC -7.9% (WSJ reports the co canceled some orders with suppliers as it struggles under the weight of mounting debt and sales declines), CATY -4.5% (agreed to submit to the FRB for review and approval a plan to maintain sufficient capital ), SID -4.2% (confirms proposal for acquisition of Cimpor), LYG -2.4% (Lloyds chief sleeps easy as challenges loom - FT), PBR -1.2% (units get $809 mln loans from Brazil - Reuters.com)... Analyst comments: PLD -2.2% (downgraded to Sell from Neutral at UBS), NTAP -1.9% (cut to Neutral at Goldman; removed from Conviction Buy list- Reuters), CAL -1.4% (downgraded to Hold from Buy at Stifel Nicolaus), CTXS -1.0% (downgraded to Sell at MKM Partners).